Forward Pharma A/S Announces Termination of its American Depositary Receipts (“ADR”) Facility
08 janv. 2024 16h00 HE
|
Forward Pharma A/S
COPENHAGEN, Denmark, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Forward Pharma A/S (“Forward” or the “Company”) today announced that its Board of Directors has approved a termination of the Deposit...
Forward Pharma A/S Announces Change in Ratio of American Depositary Shares to Ordinary Shares
07 juin 2023 08h30 HE
|
Forward Pharma A/S
COPENHAGEN, Denmark, June 07, 2023 (GLOBE NEWSWIRE) -- Forward Pharma A/S (OTC:FWPAY) (“Forward” or the “Company”) today announced that its Board of Directors has approved a change in the number of...
Forward Pharma Announces Expected Delisting of its American Depositary Shares from the Nasdaq Capital Market
19 déc. 2022 06h00 HE
|
Forward Pharma A/S
COPENHAGEN, Denmark, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward”), today announced that that on December 16, 2022 it received written notice from The Nasdaq...
Forward Pharma Announces the Decision of the Enlarged Board of Appeal of the European Patent Office in the EP2801355 Petition for Review
06 déc. 2022 14h00 HE
|
Forward Pharma A/S
COPENHAGEN, Denmark, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward” or the “Company”), today announced that the Enlarged Board of Appeal (the “EBA”) of the European...
Forward Pharma Reports Financial and Operating Results for the Year Ended December 31, 2021
08 avr. 2022 17h25 HE
|
Forward Pharma A/S
COPENHAGEN, Denmark, April 08, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported...
Forward Pharma Announces the Decision of the Technical Board of Appeal of the European Patent Office in the EP2801355 Appeal Hearing
06 sept. 2021 10h21 HE
|
Forward Pharma A/S
COPENHAGEN, Denmark, Sept. 06, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that the Technical Board of Appeal (the “TBA”) of the...
Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2020
14 avr. 2021 16h40 HE
|
Forward Pharma A/S
COPENHAGEN, Denmark, April 14, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported...
Forward Pharma Announces Rescheduling of the EP2801355 Appeal Hearing to September 6, 2021 due to COVID-19 Restrictions
12 janv. 2021 16h30 HE
|
Forward Pharma A/S
COPENHAGEN, Denmark, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that due to ongoing precautionary measures against the...
Forward Pharma Announces New Date for the EP2801355 Appeal Hearing due to COVID-19
12 mai 2020 17h00 HE
|
Forward Pharma A/S
COPENHAGEN, Denmark, May 12, 2020 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that due to current precautionary measures against the...
Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2019
24 avr. 2020 16h50 HE
|
Forward Pharma A/S
COPENHAGEN, Denmark, April 24, 2020 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported...